Akorn (AKRX) 'Worst-Case Scenario', Stock Could Settle ~$6-$8 Today - RBC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Akorn (AKRX) PT Lowered to $10 at RBC Capital
October 2, 2018 7:17 AM EDTRBC Capital analyst Randall Stanicky lowered the price target on Akorn (NASDAQ: AKRX) to $10.00 (from $27.00) while maintaining a Sector Perform rating after the negative case scenario was delivered to AKRX in a decision which means FRE will not be forced to close at $34 per... More
Akorn (AKRX) Confirms Adverse Court Ruling Related to Fresenius Deal, Plans to Appeal
October 1, 2018 9:27 AM EDTAkorn, Inc. (NASDAQ: AKRX), today issued the following statement in response to the ruling by the Delaware Chancery Court on the complaint filed by Akorn against Fresenius Kabi AG:
We are disappointed by the ruling by the Delaware Chancery Court... More
Fresenius Wins Ruling to Pull out of $4.3 Billion Akorn (AKRX) Deal - Bloomberg
October 1, 2018 8:25 AM EDTFresenius Wins Ruling to Pull out of $4.3 Billion Akorn (NASDAQ: AKRX) Deal - Bloomberg
